CIK 0001468748
- Non-accelerated filer
- Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270476525
- Phone
- +1 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale See Remarks sold 3,487 shares at an average $7.09 ($24,708)
- 4 Open-market sale See Remarks sold 4,343 shares at an average $7.09 ($30,781)
- 4 Option exercise See Remarks acquired 2,900 shares (option exercise)
- 4 Option exercise See Remarks acquired 3,025 shares (option exercise)
- 4 Open-market buy Director bought 572,349 shares at an average $7.77 ($4,448,168)
- 4 Open-market buy Director bought 350,406 shares at an average $6.75 ($2,363,748)
- 4 Open-market buy Director bought 456,690 shares at an average $5.91 ($2,696,829)
- 4 Open-market sale Chairman and CEO sold 1,340,000 shares at an average $9.15 ($12,257,688)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 400,965 shares at an average $54.45 ($21,832,153)
- 4 Open-market buy Director bought 347,665 shares at an average $52.02 ($18,084,687)
- 4 Open-market buy Director bought 501,111 shares at an average $57.49 ($28,806,796)
- 4 Open-market sale See Remarks sold 6,950 shares at an average $64.39 ($447,494)
- 4 Open-market sale See Remarks sold 6,950 shares at an average $87.60 ($608,831)
Page 4 of 10 · 193 filings